Research Square (Research Square),
Год журнала:
2022,
Номер
unknown
Опубликована: Май 11, 2022
Abstract
Purpose
Successful
deprescribing
requires
understanding
the
attitudes
of
older
adults
and
caregivers
towards
this
process.
This
study
aimed
to
capture
these
in
four
French-speaking
countries,
investigate
associated
factors.
Methods
A
multicenter
cross-sectional
was
conducted
by
administrating
French
version
revised
Patients’
Attitudes
Towards
Deprescribing
(rPATD)
questionnaire
Belgium,
Canada,
France
Switzerland.
Community-dwelling
or
nursing
home
≥
65
years
taking
1
prescribed
medications,
with
similar
characteristics
were
included.
Multivariate
logistic
regressions
carried
out
examine
factors
willingness
deprescribe.
Results
total
367
(79.3
±
8.7
years,
63%
community-dwelling,
54%
≥5
medications)
255
unrelated
(64.4
12.6
years)
care
recipients
(83.4
7.9
52%
69%
answered
questionnaire.
Among
them,
87.5%
75.6%
would
be
willing
stop
medications
if
physician
said
it
possible.
Reluctance
a
medication
taken
for
long
time
expressed
46%
both
caregivers.
low
score
factor
“concerns
about
stopping”
[older
adults:
aOR:
0.21;
95%CI:
0.07–0.59],
high
“involvement”
2.66;
1.01–7.07;
caregivers:
11.28;
1.48–85.91]
Conclusions
significant
proportion
speaking
countries
are
open
deprescribing.
Despite
apparent
willingness,
conversations
clinical
practice
remains
marginal,
emphasizing
importance
optimizing
integration
existing
tools
such
as
rPATD.
The Journals of Gerontology Series A,
Год журнала:
2021,
Номер
77(5), С. 1020 - 1034
Опубликована: Авг. 14, 2021
Abstract
Background
Harmful
and/or
unnecessary
medication
use
in
older
adults
is
common.
This
indicates
deprescribing
(supervised
withdrawal
of
inappropriate
medicines)
not
happening
as
often
it
should.
study
aimed
to
synthesize
the
results
Patients’
Attitudes
Towards
Deprescribing
(PATD)
questionnaire
(and
revised
versions).
Methods
Databases
were
searched
from
January
2013
March
2020.
Google
Scholar
was
used
for
citation
searching
development
and
validation
manuscripts
identify
original
research
using
validated
PATD,
PATD
(older
adult
caregiver
versions),
version
people
with
cognitive
impairment
(rPATDcog).
Two
authors
extracted
data
independently.
A
meta-analysis
proportions
(random-effects
model)
conducted
subgroup
meta-analyses
setting
population.
The
primary
outcome
question:
“If
my
doctor
said
possible,
I
would
be
willing
stop
one
or
more
medicines.”
Secondary
outcomes
associations
between
participant
characteristics
other
(r)PATD
results.
Results
We
included
46
articles
describing
40
studies
(n
=
10,816
participants).
found
proportion
participants
who
agreed
strongly
this
statement
84%
(95%
CI
81%–88%)
80%
74%–86%)
patients
caregivers,
respectively,
significant
heterogeneity
(I2
95%
77%).
Conclusion
Consumers
reported
willingness
have
a
deprescribed
although
should
interpreted
caution
due
heterogeneity.
findings
moves
toward
understanding
attitudes
deprescribing,
which
could
increase
discussion
uptake
recommendations
clinical
practice.
Journal of Clinical Pharmacy and Therapeutics,
Год журнала:
2018,
Номер
43(4), С. 550 - 555
Опубликована: Апрель 22, 2018
What
is
known
and
objective
Deprescribing
the
process
of
discontinuing
or
reducing
dosage
medications
that
are
no
longer
appropriate
aligned
with
goals
care,
which
paramount
in
elderly
patients
multiple
comorbidities
polypharmacy.
The
this
study
was
to
assess
perceptions
primary
care
physicians
on
deprescribing
for
potential
barriers
experience
Local
Health
Authority
(LHA)
Parma,
Emilia-Romagna,
Italy.
Methods
One
hundred
sixty
(57%
total
number
Parma)
attended
an
educational
session
related
were
asked
anonymously
complete
a
paper
survey.
Participants
their
level
agreement
nine
questions
about
perception
factors
affecting
using
seven-point
Likert-type
scale.
A
correlation
coefficient
calculated
association
between
physicians'
confidence
attitudes
associated
deprescribing.
Results
discussion
Many
(72%)
reported
general
ability
deprescribe.
Most
respondents
(78%)
they
comfortable
preventive
medications,
yet
only
half
(53%)
guideline-recommended
therapies.
Lack
evidence
medicines
concern
withdrawal
side
effects
impede
by
more
than
one-third
physicians.
When
initially
prescribed
another
physician,
40%
hesitance
them.
About
(45%)
did
not
feel
when
patients/caregivers
believed
continuation
medication
needed.
time
difficulty
engaging
cited
as
one
four
There
strong
new
conclusion
results
show
believe
generally
deprescribing,
although
there
still
several
hamper
engage
process.
An
improved
understanding
views
may
help
guide
further
research,
policies
remain
healthy
while
streamlining
regimen.
The Lancet Planetary Health,
Год журнала:
2024,
Номер
8(5), С. e327 - e333
Опубликована: Май 1, 2024
Health
care
contributes
4·4%
of
global
net
carbon
emissions.
Hospitals
are
resource-intensive
settings,
using
a
large
amount
supplies
in
patient
and
have
high
energy,
ventilation,
heating
needs.
This
Viewpoint
investigates
emissions
related
to
health
patient's
last
year
life.
End
life
(EOL)
is
period
when
health-care
use
associated
production
increases
exponentially
due
primarily
hospital
admissions,
which
often
at
odds
with
patients'
values
preferences.
Potential
solutions
detailed
within
this
facilitating
advanced
plans
patients
ensure
their
EOL
wishes
clear,
beginning
palliative
interventions
earlier
treating
life-limiting
illness,
deprescribing
unnecessary
medications
because
supply
chains
make
up
significant
portion
emissions,
and,
enhancing
access
low-intensity
community
settings
(eg,
hospices)
the
if
home
not
available.
Our
analysis
was
done
Canadian
data,
but
findings
can
be
applied
other
high-income
countries.
Abstract
Background
Efforts
are
needed
to
strengthen
evidence
and
guidance
for
appropriate
deprescribing
older
nursing
home
(NH)
residents,
who
disproportionately
affected
by
polypharmacy
inappropriate
prescribing.
Given
the
challenges
of
conducting
randomized
drug
withdrawal
studies
in
this
population,
data
from
observational
routinely
collected
healthcare
can
be
used
identify
patients
apparent
candidates
evaluate
subsequent
health
outcomes.
To
improve
design
interpretation
examining
determinants,
risks,
benefits
specific
medications
NH
we
sought
propose
a
conceptual
framework
determinants
residents.
Methods
We
conducted
scoping
review
patterns
potential
discontinuing
or
de-intensifying
(i.e.,
reducing)
searched
PubMed
through
September
2021
included
meeting
following
criteria:
among
adults
aged
65
+
setting;
(2)
study
designs;
(3)
discontinuation
de-intensification
as
primary
outcome
with
key
independent
variables.
conceptualized
behavior
social-ecological
lens,
potentially
influenced
factors
at
intrapersonal,
interpersonal,
organizational,
community,
policy
levels.
Results
Our
search
identified
250
relevant
published
2021.
A
total
14
were
inclusion
subsequently
synthesized
group
into
domains
spanning
five
core
resulting
acknowledges
that
is
strongly
patient-level
clinical
modify
expected
risks
deprescribing,
including
index
condition
attributes
(e.g.,
disease
severity),
medication
being
considered
co-prescribed
medications,
prognostic
factors.
It
also
incorporates
hierarchical
influences
interpersonal
differences
relating
providers
family
caregivers,
facility
system
organizational
structures,
community
trends
norms,
finally
policies.
Conclusions
proposed
will
serve
useful
tool
future
seeking
use
sources
designs
Abstract
Background
The
recently
developed
Screening
Tool
of
Older
Persons'
Prescriptions
in
Frail
adults
with
a
limited
life
expectancy
(STOPPFrail)
criteria
can
be
helpful
for
screening
medications
(PIMs),
but
it
is
yet
to
widely
used
clinical
practice.
Herein,
we
aimed
investigate
the
prevalence
PIMs
based
on
STOPPFrail
(STOPPFrail-PIM)
among
frail
older
admitted
geriatric
center.
Methods
This
was
retrospective
cross-sectional
study
conducted
center
at
an
academic
tertiary
care
hospital
Korea.
We
evaluated
who
received
comprehensive
assessment
(CGA)
between
1
January,
2019
and
30
June,
2020.
were
identified
by
geriatricians
records
STOPPFrail-PIMs
analysed
trained
pharmacists.
Descriptive
analysis,
t-test,
chi-square
test
using
IBM
SPSS
software
version
25.0.
Results
Among
504
underwent
CGA
after
admission,
171
included
study.
An
average
11.3
±
4.7
administered
regularly
each
patient
before
admission.
Overall,
97.1%
(166/171)
had
least
one
STOPPFrail-PIM,
mean
number
STOPPFrail-PIM
4.2
2.8.
Drugs
without
clear
indication
(A2)
most
frequent
pre-admission
followed
lipid-lowering
therapies
(B1)
neuroleptic
antipsychotics
(D1).
significantly
lower
discharge
than
that
decrease
being
highest
A2
94.7%.
Conclusions
Most
rate
decreased
multidisciplinary
team
care.
Further
studies
are
needed
association
use
adverse
consequences
adults.
Current Epidemiology Reports,
Год журнала:
2021,
Номер
8(3), С. 116 - 129
Опубликована: Апрель 23, 2021
Abstract
Purpose
of
Review
To
describe
approaches
to
measuring
deprescribing
and
associated
outcomes
in
studies
patients
approaching
end
life
(EOL).
Recent
Findings
We
reviewed
published
through
2020
that
evaluated
with
limited
expectancy
EOL.
Deprescribing
includes
reducing
the
number
medications,
decreasing
medication
dose(s),
eliminating
potentially
inappropriate
medications.
Tools
such
as
STOPPFrail,
OncPal,
Unnecessary
Drug
Use
Measure
can
facilitate
deprescribing.
Outcome
measures
vary
selection
should
align
operationalized
definition
used
by
study
investigators.
Summary
EOL
considerations
include
appropriateness
context
patient
goals
for
care,
expected
benefit
from
given
expectancy,
heightened
potential
medication-related
harm
death
nears.
Additional
data
are
needed
on
how
impacts
quality
life,
caregiver
burden,
out-of-pocket
costs
caregivers.
Investigators
design
this
information
mind.
Farmacia Hospitalaria,
Год журнала:
2023,
Номер
48(2), С. 83 - 89
Опубликована: Сен. 26, 2023
Patients
with
life-limiting
illnesses
are
prone
to
unnecessary
polypharmacy.
Deprescribing
tools
may
contribute
minimizing
negative
outcomes.
Thus,
the
aims
of
study
were
identify
validated
instruments
for
deprescribing
inappropriate
medications
patients
palliative
care
needs
and
assess
impact
on
clinical,
humanistic,
economic